METASTRON 37 MBq 37 MBq / ml injectible solution medication leaflet

V10BX01 strontium chloride • Various | Pain palliation (bone seeking agents) | Various pain palliation radiopharmaceuticals

Strontium chloride is a chemical compound used in nuclear medicine for the diagnosis of certain bone conditions. It is used as a radioactive contrast agent, allowing the visualization of bone structures during imaging scans.

The medication is administered intravenously, as directed by a doctor, prior to the scan. It is important for patients to follow the doctor's instructions to ensure accurate results.

Patients should be aware of potential side effects, such as injection site reactions or allergic reactions. It is important to inform the doctor of any unusual symptoms.

Common side effects include injection site reactions and nausea. In rare cases, severe reactions such as serious allergic reactions may occur. Patients should be informed of these risks before the procedure.

General data about METASTRON 37 MBq 37 MBq / ml

Substance: strontium chloride

Date of last drug list: 01-12-2020

Commercial code: W67029001

Concentration: 37 MBq / ml

Pharmaceutical form: injectible solution

Quantity: 1

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: GE HEALTHCARE LIMITED - MAREA BRITANIE

Holder: GE HEALTHCARE B.V. - TARILE DE JOS

Number: 8755/2016/01

Shelf life: 28 days de la data de referinta

Other substances similar to strontium chloride